NB-BIODAPA 10 (dapagliflozin tablet 10 mg)

NB-Biodapa 10 contains Dapagliflozin 10 mg, an oral medication used to manage blood sugar levels in individuals with type 2 diabetes. Dapagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor that works by preventing the kidneys from reabsorbing glucose, thereby increasing glucose excretion through urine and lowering blood sugar levels. This medication also helps reduce the risk of heart failure, kidney damage, and other complications associated with diabetes. NB-Biodapa 10 can be used alone or in combination with other diabetes medications, along with diet and exercise, to improve glycemic control and reduce the risk of long-term diabetic complications.